loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people. . .
-
.
.
however, bentley also warned that these treatments can be hazardous as they may cause bleeding which becomes more likely as the amount of svd increases. .